Get started
Author

Amber A. Rivera

Observed names: A. Rivera, Amber Rivera
OpenAlex ID: A5111746752
Nanomolar-potency ‘co-potentiator’ therapy for cystic fibrosis caused by a defined subset of minimal function CFTR mutants
2019 · Puay-Wah Phuan, Joseph-Anthony Tan, et al. · Scientific Reports · 68
PDF
SLC26A3 inhibitor identified in small molecule screen blocks colonic fluid absorption and reduces constipation
2018 · Peter M. Haggie, Onur Cil, et al. · JCI Insight · 57
PDF
Analytical Validation of a Highly Quantitative, Sensitive, Accurate, and Reproducible Assay (HERmark®) for the Measurement of HER2 Total Protein and HER2 Homodimers in FFPE Breast Cancer Tumor Specimens
2010 · Jeffrey S. Larson, Laurie J. Goodman, et al. · Pathology Research International · 51
PDF
CFTR modulator therapy for cystic fibrosis caused by the rare c.3700A>G mutation
2020 · Puay-Wah Phuan, Peter M. Haggie, et al. · Journal of Cystic Fibrosis · 22
Repurposing calcium-sensing receptor agonist cinacalcet for treatment of CFTR-mediated secretory diarrheas
2021 · Apurva A. Oak, Parth D. Chhetri, et al. · JCI Insight · 21
PDF
SLC26A6-selective inhibitor identified in a small-molecule screen blocks fluid absorption in small intestine
2021 · Onur Cil, Peter M. Haggie, et al. · JCI Insight · 20
PDF
Emergence of resistance-associated variants after failed triple therapy with vaniprevir in treatment-experienced non-cirrhotic patients with hepatitis C-genotype 1 infection: A population and clonal analysis
2013 · Richard J.O. Barnard, Carolyn M. McHale, et al. · Virology · 20
Transport Reversal during Heteroexchange: A Kinetic Study
2013 · V. Makarov, L. Kucheryavykh, et al. · Journal of Biophysics · 13
PDF
Synthesis and evaluation of tetrahydropyrazolopyridine inhibitors of anion exchange protein SLC26A4 (pendrin)
2019 · Jie S. Zhu, Julia Y. Lu, et al. · Bioorganic & Medicinal Chemistry Letters · 2
Works count: 9
Citation count: 274
H-index: 8
I10-index: 8
Year
Topic
Type